Akademisyen

EMRAH OKUR

DOKTOR ÖĞRETİM ÜYESİ

KÜTAHYA DUMLUPINAR ÜNİVERSİTESİ FEN-EDEBİYAT FAKÜLTESİ BİYOLOJİ BÖLÜMÜ

Ana Dal Fen Bilimleri ve Matematik Temel Alanı
Yan Dal Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

Makale 10
Proje 0
Kitap 1
Bildiri 9
Patent 0
Sanatsal 0

Scopus (SJR) Q1 4 Q2 2 Q3 4 Q4 0

WoS (JCR) Q1 2 Q2 2 Q3 3 Q4 3

TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0

Üst %10 makale 0

Ort. yüzdelik 65.1%

Üst %1 payı 0.0%

Üst %10 payı 0.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Makale listesi

2023 Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa MEDICAL ONCOLOGY DOI 10.1007/s12032-023-02173-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 49.5%
2020 An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line CYTOTECHNOLOGY DOI 10.1007/s10616-019-00362-x YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.7%
2019 A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis CELL BIOLOGY AND TOXICOLOGY DOI 10.1007/s10565-018-9435-z YÖKSİS SJR Q1 JCR Q1 OpenAlex 64.3%
2017 Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line Cytotechnology DOI 10.1007/s10616-017-0079-2 YÖKSİS SJR Q2 JCR Q3 OpenAlex 83.4%
2016 Effects of p38 MAP kinase inhibitors on MDAMB 231 cell line The FEBS Journal DOI 10.1111/febs.13808 YÖKSİS SJR Q1 JCR Q2 OpenAlex 11.3%
2016 A novel combination treatment for breast cancer cells involving BAPTA AM and proteasome inhibitor bortezomib Oncology Letters DOI 10.3892/ol.2016.4597 YÖKSİS SJR Q3 JCR Q4 OpenAlex 74.5%
2015 A proteomic analysis of p53 independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line Journal of Proteomics DOI 10.1016/j.jprot.2014.09.010 YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.6%
2014 Data for a proteomic analysis of p53 independent induction of apoptosis by bortezomib Data in Brief DOI 10.1016/j.dib.2014.09.003 YÖKSİS SJR Q3 JCR Q3
2012 The p53 independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib Tumor Biology DOI 10.1007/s13277-012-0386-3 YÖKSİS SJR Q1 JCR Q3 OpenAlex 86.5%
2010 Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line Molecular Medicine Reports DOI 10.3892/mmr_00000262 YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.6%

Akademisyenlere dön